Determination of azithromycin in human plasma by HPLC-MS and its relative bioavailability

Chinese Pharmaceutical Journal

Volumn 41, Issue 1, 2006, Pages 51-54

  Wang, Yu Hua ^a   Chen, Jun Jie ^a   Chen, Ben Mei ^b   Zhang, Bi Kui ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Azithromycin; Bioavailability; HPLC MS; Pharmacokinetics

Indexed keywords

AZITHROMYCIN;

ACCURACY; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG HALF LIFE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MASS SPECTROMETRY; NORMAL HUMAN;

EID: 33645910531     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. KOYTCHEV R, OZALP Y, ERENMEMISOGLU A, et al. Assessment of the bioequivalence of different foundations containing azithromycin (tablets and suspension)[J]. Arzneimittelforsch, 2004, 54(9a):578-582.
2. GANDHI R, KAUL C L, PANCHAGNULA R. Pharmacokinetic evaluation of an azithromycin controlled release dosage form in healthy human volunteers: a single dose study[J]. Int J Pharm, 2004, 270(1-2): 1-8.
3. LI D, WANG D G, NIE Z Y, et al. HPLC assay of azithromycin in human serum[J]. Chin J Clin Pharm, 2003, 12(6):353-355.
4. KEES F, SPANGLER S, WELLENHOFER M. Detemination of macrolides in biological matrices by high-performance liquid chromatagraphy with electrochemical detection[J]. J Chromatgr A, 1998, 812(1-2):287-293.
5. SHI J, SONG H J, LI Z, et al. Pharmacokinetics and relative bioavailability of azithromycin tablets[J]. Chin J Pharm 2001, 32(5):215-217.